To direct the Secretary of Health and Human Services to award grants for research, investigation, and awareness of the effect of personal care products containing endocrine-disrupting chemicals on the female reproductive system, and for other purposes.
Analysis under review: This bill has generated analysis that may be too generic or incomplete. Clause-level evidence remains available below.
Summary
What This Bill Does
This bill, To direct the Secretary of Health and Human Services to award grants for research, investigation, and awareness of the effect of personal care products containing endocrine-disrupting chemicals on the female reproductive system, and for other purposes., changes federal law or congressional policy affecting health care providers and patients. The main policy domain is Healthcare, Government Operations, Environment.
Who Benefits and How
health care providers and patients may benefit from new authority, funding, eligibility, regulatory clarity, or reduced risk created by the bill.
Who Bears the Burden and How
federal implementing agencies, health care providers and patients may take on implementation duties, reporting obligations, compliance costs, or oversight responsibilities.
Key Provisions
- Section H2A3CB78205544A73BD44B3E39D4235DE: 1. Short title This Act may be cited as the Health and Endocrine Research on personal care products for women Act or the HER Act.
- Section HCB5F205EB903423DB0866E36F41055E6: 2. Grants for research, investigation, and awareness regarding endocrine-disrupting chemicals in personal care products The Secretary of Health and Human...
Evidence Chain:
This summary is generated from the full bill text using AI analysis. Expand "Detailed Analysis" below for identified beneficiaries/burden bearers with clause-level evidence links.
At a Glance
What This Bill Does
This bill, To direct the Secretary of Health and Human Services to award grants for research, investigation, and awareness of the effect of personal care products containing endocrine-disrupting chemicals on the female reproductive system, and for other purposes., changes federal law or congressional policy affecting health care providers and patients.
Key Policy Areas
Healthcare, Government Operations, Environment
Primary Purpose
This bill, To direct the Secretary of Health and Human Services to award grants for research, investigation, and awareness of the effect of personal care products containing endocrine-disrupting chemicals on the female reproductive system, and for other purposes., changes federal law or congressional policy affecting health care providers and patients.
Policy Domains
Whole bill
Identified Gains
- health care providers and patients
Identified Costs
- federal implementing agencies
- health care providers and patients
Sponsors
Legislative Progress
IntroducedMs. Brown (for herself, Mrs. McIver, Mr. Johnson of Georgia, …
Impact analysis is available but no clear stakeholder effects identified. View clause-level analysis →
Bill Structure & Actor Mappings
Who is "The Secretary" in each section?
- "secretary_of_health_and_human_services"
- → Secretary of Health and Human Services
Key Definitions
Terms defined in this bill
the Secretary of Health and Human Services. The term State means— each of the several States, the District of Columbia, and the territories of the United States
We use a combination of our own taxonomy and classification in addition to large language models to assess meaning and potential beneficiaries. High confidence means strong textual evidence. Always verify with the original bill text.
Learn more about our methodology